Project partners

DECIDER was a multidisciplinary research project bringing together expertise from 16 research groups and companies in 14 organizations located in seven European countries, in order to develop diagnostic tools and improve the treatment options for high-grade serous ovarian cancer. The expertise of the partners ranged from clinical medicine, genomics, molecular biology, computer science and Artificial Intelligence all the way to biomedical and privacy laws.

For the partner descriptions, click on the logos below.